American Oncology Network
Closed (deSPAC)Health Care · oncology practice management services
- What it is
- Oncology Network, LLC The American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology
- What it’s doing now
- Merging with Digital Transformation Opportunities Corp. (DTOC) — closed (despac).
- What you should know
- Data is still being assembled for this company — what is shown below is everything we have verified so far.
The business, per its filings
SEC primaryOncology Network, LLC The American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 106 physicians practicing across 17 states. The executive management team of AON encompasses members with an average of more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients. Learn more at www.aoncology.com .
Source: S-4/A, accession 0001104659-23-081125
What the company says about itself
Web research — not auditedThe American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders launched in 2018 to ensure the long-term success of community oncology. It is a rapidly growing network representing physicians, nurse practitioners, and physician assistants across multiple care sites. AON provides comprehensive support, ancillary services, and practice management expertise, including centralized specialty pharmacy, diagnostics, pathology, integrated electronic medical records, and care management teams.
- Markets:
- Oncology | Healthcare Practice Management
- Products:
- Centralized specialty pharmacy | Diagnostics | Pathology | Electronic medical records | Care management | Financial assistance programs | Enhancing Oncology Model program participation | Oral oncolytic pharmacy | Clinical lab
[WEB-INTEL 2026-08-26] 4 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Net cash used in investing activities was $2.4 million for the year ended December 31, 2024 compared to $35.5 million for the comparable period." [https://docs.publicnow.com/viewDoc.aspx?filename=183423%5CEXT%5C30A905351796B0F07FA824236365284C7489B321_589FA8873AD63E6133C370A03633F708AD4A9C3D.PDF] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "on October 5, 2022, Digital Transformation Opportunities Corp., a Delaware corporation ("DTOC"), entered into a Business Combination Agreement with AON" [https://investors.aoncology.com/node/7356/html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "successfully completed their merger, starting from September 21, 2023." [https://www.facebook.com/beststocks2/posts/american-oncology-network-llc-aon-and-digital-transformation-opportunities-corp-/325406286713153/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Announce Completion of Business Combination September 20, 2023." [https://www.aoncology.com/2023/09/20/american-oncology-network-digital-transformation-opportunities-announce-completion-business-combination/]
Source: https://www.aoncology.com/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.
The deal it’s entering
American Oncology Network is merging with Digital Transformation Opportunities Corp. (DTOC) currently marked Closed (deSPAC).
| Headline equity value | — |
Structure per SEC accession(s) 0001104659-23-051785. How to read these numbers: headline vs effective valuation · what a definitive agreement commits
What exactly is being valued, and at what
Common questions
Is American Oncology Network going public?
American Oncology Network has an approved merger with the SPAC Digital Transformation Opportunities Corp. (DTOC). Deal status: Closed (deSPAC).
Does American Oncology Network have revenue?
The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.
Educational content, not investment advice.
- Oak Hill Bio — with RACC ($160M) · pre-revenue
- Longevity Biomedical — with FTII ($100M) · pre-revenue
- GNQ Insilico — with IBAC ($500M)
- HCC Healthcare Pte. — with RFAM ($500M)
- OmniAb — with AHPA
- Jasper Therapeutics — with AMHC